<SEC-DOCUMENT>0000885725-22-000011.txt : 20220427
<SEC-HEADER>0000885725-22-000011.hdr.sgml : 20220427
<ACCEPTANCE-DATETIME>20220427063520
ACCESSION NUMBER:		0000885725-22-000011
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220427
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220427
DATE AS OF CHANGE:		20220427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		22856214

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bsx-20220427.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:23507074-9282-432b-a3e4-de757637ff25,g:77782b89-5359-4ad2-bba8-4b7412420161,d:0948e48740df4614b976db6a02f864b6--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:bsx="http://www.bostonscientific.com/20220427" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20220427</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl80L2ZyYWc6OTMzYzk4ZmY1OWE4NDNmOGJlNjg4ZDdlOGRkNjA0MmYvdGFibGU6ZjhkMzBiZGVjZWNkNGM4Njk3YzdjODJhZjg2MTI5MzQvdGFibGVyYW5nZTpmOGQzMGJkZWNlY2Q0Yzg2OTdjN2M4MmFmODYxMjkzNF8yLTEtMS0xLTY4OTc1_f7287cb7-2f93-48da-b33f-382a3fe5ecb8">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl80L2ZyYWc6OTMzYzk4ZmY1OWE4NDNmOGJlNjg4ZDdlOGRkNjA0MmYvdGFibGU6ZjhkMzBiZGVjZWNkNGM4Njk3YzdjODJhZjg2MTI5MzQvdGFibGVyYW5nZTpmOGQzMGJkZWNlY2Q0Yzg2OTdjN2M4MmFmODYxMjkzNF81LTEtMS0xLTY4OTc1_b0be00be-657a-42ca-911f-13d1b0a78e4f">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20220427.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-27</xbrli:startDate><xbrli:endDate>2022-04-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb4a424e51c34eb6b267543ce629927f_D20220427-20220427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-27</xbrli:startDate><xbrli:endDate>2022-04-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i251eeeeb4e07422da696af078158cb33_D20220427-20220427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-27</xbrli:startDate><xbrli:endDate>2022-04-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61064d33ffc241bea390f6765d527888_D20220427-20220427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-27</xbrli:startDate><xbrli:endDate>2022-04-27</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i0948e48740df4614b976db6a02f864b6_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">_____________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDUy_433644c5-d606-4d10-bec0-2f7dc5f9a0de">8-K</ix:nonNumeric>  </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">_____________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8zNjc_cac18df7-b62e-4737-bb94-373fa0818c39">April 27, 2022</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDUz_28d48206-d18e-4492-b078-ee96c952c3c4">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6NmQzN2I4NzY5ZWY0NDc3NDhkYmY2Zjk5MGYzOGJlYTMvdGFibGVyYW5nZTo2ZDM3Yjg3NjllZjQ0Nzc0OGRiZjZmOTkwZjM4YmVhM18wLTAtMS0xLTY4OTc1_9f0af190-78e5-4b54-a884-fcbb3c0b55ec">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6NmQzN2I4NzY5ZWY0NDc3NDhkYmY2Zjk5MGYzOGJlYTMvdGFibGVyYW5nZTo2ZDM3Yjg3NjllZjQ0Nzc0OGRiZjZmOTkwZjM4YmVhM18wLTItMS0xLTY4OTc1_9fc12eb2-5b1c-4db9-a3de-e837422bbfb2">1-11083</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6NmQzN2I4NzY5ZWY0NDc3NDhkYmY2Zjk5MGYzOGJlYTMvdGFibGVyYW5nZTo2ZDM3Yjg3NjllZjQ0Nzc0OGRiZjZmOTkwZjM4YmVhM18wLTQtMS0xLTY4OTc1_1b80a121-a68a-4fa0-8901-f50021db5bf0">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDU0_42902cf9-c841-4572-845c-94d9ad06595b">300 Boston Scientific Way</ix:nonNumeric>, <ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDQ4_7cd20ef1-2fc2-4285-9442-e6a945c7bfcd">Marlborough</ix:nonNumeric>, <ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDU1_72f73408-1ceb-470b-b9c8-e33124c8832b">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDQ5_38367582-b3cf-44cd-9bb6-386c1fc756f3">01752-1234</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;             &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDUw_1107445f-0edb-4d29-bfc2-d5fc15881a53">508</ix:nonNumeric> <ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDU2_35b59e2e-ff83-4b9b-a124-8fd5081f4bef">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6MGY2ZDIyNmM4MWJiNGY1NmJkYTIwZDE3MGNlYjQ5MTMvdGFibGVyYW5nZTowZjZkMjI2YzgxYmI0ZjU2YmRhMjBkMTcwY2ViNDkxM18wLTAtMS0xLTY4OTc1_2e1afbb1-6259-4549-a422-fbb5fcfca98a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6MGY2ZDIyNmM4MWJiNGY1NmJkYTIwZDE3MGNlYjQ5MTMvdGFibGVyYW5nZTowZjZkMjI2YzgxYmI0ZjU2YmRhMjBkMTcwY2ViNDkxM18yLTAtMS0xLTY4OTc1_42c7c74a-a06e-459d-9ea0-7aed9b95a7a3">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6MGY2ZDIyNmM4MWJiNGY1NmJkYTIwZDE3MGNlYjQ5MTMvdGFibGVyYW5nZTowZjZkMjI2YzgxYmI0ZjU2YmRhMjBkMTcwY2ViNDkxM180LTAtMS0xLTY4OTc1_5cf1efb0-0129-4011-88b8-e4a1b21d57ef">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6MGY2ZDIyNmM4MWJiNGY1NmJkYTIwZDE3MGNlYjQ5MTMvdGFibGVyYW5nZTowZjZkMjI2YzgxYmI0ZjU2YmRhMjBkMTcwY2ViNDkxM182LTAtMS0xLTY4OTc1_4af56113-ef7a-4b70-b39d-adb7b0193c4a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.414%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb4a424e51c34eb6b267543ce629927f_D20220427-20220427" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18xLTAtMS0xLTY4OTc1_5c180c5b-d39a-44b7-9041-df54df0fa490">Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb4a424e51c34eb6b267543ce629927f_D20220427-20220427" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18xLTItMS0xLTY4OTc1_c7af3bb5-af38-40f1-9b14-996708d9b36c">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb4a424e51c34eb6b267543ce629927f_D20220427-20220427" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18xLTQtMS0xLTY4OTc1_80833b14-5dfd-4ca4-8f0c-4fd818ed73f4">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i251eeeeb4e07422da696af078158cb33_D20220427-20220427" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18yLTAtMS0xLTY4OTc1_debe8456-3952-44d0-a33c-4f9efe9c2afd">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i251eeeeb4e07422da696af078158cb33_D20220427-20220427" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18yLTItMS0xLTY4OTc1_3b5e0f33-d1b0-4393-ab1a-ca40268906e3">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i251eeeeb4e07422da696af078158cb33_D20220427-20220427" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18yLTQtMS0xLTY4OTc1_61df86f9-e886-4b12-92eb-cf7a1bf88e14">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61064d33ffc241bea390f6765d527888_D20220427-20220427" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18zLTAtMS0xLTY4OTc1_ebac21b6-3f22-47e9-bbee-7ccbf66b6d00">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61064d33ffc241bea390f6765d527888_D20220427-20220427" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18zLTItMS0xLTY4OTc1_8d55d403-1221-402d-aa6a-b34884f534a2">BSX PR A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61064d33ffc241bea390f6765d527888_D20220427-20220427" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18zLTQtMS0xLTY4OTc1_44c17c89-44c6-4d38-9c05-56a9ff2796c6">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDUx_f5b51733-4968-46aa-a192-48771901f533">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i0948e48740df4614b976db6a02f864b6_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.02.&#160;&#160;&#160;&#160;RESULTS OF OPERATIONS AND FINANCIAL CONDITION.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;27, 2022, Boston Scientific Corporation (the "Company") issued a press release announcing financial results for the first quarter ended March&#160;31, 2022.  A copy of the release is furnished with this report as Exhibit 99.1. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.01. &#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND EXHIBITS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;Exhibits</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit No.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Description</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="q12022earningsrelease.htm">Press Release issued by Boston Scientific Corporation dated April 27, 2022</a></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;document</span></div><div><span><br/></span></div><div id="i0948e48740df4614b976db6a02f864b6_10"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BOSTON SCIENTIFIC CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Susan J. Thompson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Susan J. Thompson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Corporate Counsel, and Assistant Secretary</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>q12022earningsrelease.htm
<DESCRIPTION>EX-99.1 Q1 2022 EARNINGS RELEASE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i311b071536f440e0adcda33dd385265e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:36pt"><img alt="image.jpg" src="image.jpg" style="height:98px;margin-bottom:5pt;vertical-align:text-bottom;width:678px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR IMMEDIATE RELEASE</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2022</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Marlborough, Mass. (April&#160;27, 2022) -- Boston Scientific Corporation (NYSE&#58; BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing 10.0 percent on a reported basis, 12.6 percent on an operational</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> basis and 9.7 percent on an organic</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> basis, all compared to the prior year period. The company reported GAAP net income available to common stockholders of $97 million or $0.07 per share (EPS), compared to $327 million or $0.23 per share a year ago, and achieved adjusted EPS of $0.39 for the period, compared to $0.37 a year ago.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;Our growth this quarter was fueled by strong execution from our global team, our innovative portfolio and improved procedure volume,&#8221; said Mike Mahoney, chairman and chief executive officer, Boston Scientific. &#8220;We are pleased with our first quarter performance and outlook for the full year, despite the impact of macroeconomic headwinds, and we look forward to bringing meaningful innovation to customers and the patients we serve together.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">First quarter financial results and recent developments&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Reported net sales of $3.026 billion, representing an increase of 10.0 percent on a reported basis, compared to the company's guidance range of 5 to 8 percent&#59; 12.6 percent on an operational basis&#59; and 9.7 percent on an organic basis, compared to the company's guidance range of 5 to 8 percent, all compared to the prior year period. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Reported GAAP net income available to common stockholders of $0.07 per share, compared to the company's guidance range of $0.16 to $0.20 per share, and achieved adjusted EPS of $0.39 per share, compared to the guidance range of $0.38 to $0.40 per share.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Achieved net sales growth in each reportable segment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, compared to the prior year period&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">MedSurg&#58; 9.1 percent reported, 11.1 percent operational and 8.0 percent organic </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">Cardiovascular&#58; 11.4 percent reported, 14.5 percent operational and 10.8 percent organic</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Achieved the following regional</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> net sales growth, compared to the prior year period&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">U.S.&#58; 12.8 percent reported and operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">EMEA (Europe, Middle East and Africa)&#58; 3.3 percent reported and 12.0 percent operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">APAC (Asia-Pacific)&#58; 9.3 percent reported and 13.6 percent operational</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.11pt">Emerging Markets</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; 22.8 percent reported and 28.7 percent operational</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.15pt">Announced real-world data from the SURPASS 45-day analysis of more than 16,000 patients with the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">WATCHMAN FLX&#8482; Left Atrial Appendage Closure Device</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> from the National Cardiovascular Data (NCDR) Registry Left Atrial Appendage Occlusion (LAAO) Registry, as well as final one-year results from the FLXibility post-approval study with the device in Europe, both demonstrating low rates of adverse events and high rates of LAA closure in everyday clinical practice. Also received approval for the WATCHMAN FLX device in China by the National Medical Products Administration (NMPA) and will begin a limited market release in the coming months. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Announced at the European Heart Rhythm Association (EHRA) annual meeting acute, real-world outcomes from the POLAR ICE study, which demonstrated that the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">POLARx&#8482; Cryoablation System</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> met safety and efficacy endpoints when used to perform pulmonary vein isolation (PVI) for the ablation treatment of atrial fibrillation. A low rate of procedure-related complications, a high rate of acute PVI, and short procedure and left-atrial dwell times was also observed.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Received U.S. Food and Drug Administration (FDA) clearance for the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EMBOLD&#8482; Fibered Coil</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a fully retractable coil indicated for arterial and venous embolization in the peripheral vasculature. The EMBOLD Fibered Coil enhances the existing Boston Scientific embolization portfolio. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Received FDA investigational device exemption (IDE) to commence the FRONTIER study, a clinical trial assessing </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TheraSphere&#8482; Y-90 Glass Microspheres</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as a treatment option for patients with recurrent glioblastoma, an aggressive type of cancer that can occur in the brain. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Received FDA approval for next-generation Image Guided Programming Software for Deep Brain Stimulation Therapy. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Vercise&#8482; Neural Navigator with STIMVIEW&#8482; XT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> enables clinicians to both visualize real-time lead placement and stimulation  modeling of the brain anatomy in patients with Parkinson&#8217;s disease or essential tremor.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Received National Medical Products Administration (NMPA) approval in China for </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Rez&#363;m&#8482; Water Vapor Therapy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Rez&#363;m System is a minimally invasive treatment for benign prostatic hyperplasia (BPH), which affects up to 62 percent of men globally who have a prostate and are over 50 years of age. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.15pt">Received Health Canada approval for the first-of-its kind </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">LithoVue&#8482; Elite Single-Use Digital Flexible Ureteroscope </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with pressure monitoring</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%"> StoneSmart&#8482; Connect Console</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. The LithoVue Elite System is designed to allow physicians to monitor intrarenal pressure during ureteroscopy procedures to make pressure-related decisions in real time.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Completed in mid-February the acquisition of Baylis Medical Company Inc., a company that offers advanced transseptal access solutions as well as guidewires, sheaths and dilators used to support catheter-based left-heart procedures. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Completed a public offering of &#8364;3 billion ($3.3 billion) aggregate principal amount of EUR-denominated Senior Notes, and tender offer and early redemption of $3.3 billion aggregate principal amount of certain outstanding USD-denominated Senior Notes.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#fa0000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:105%">1. Operational net sales growth excludes the impact of foreign currency fluctuations.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">2. Organic net sales growth excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">3 We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">4. In the first quarter of 2022, we reorganized our operational structure and have aggregated our core businesses, each of which generate revenues from the sale of medical devices (Medical Devices), into two reportable segments comprised of MedSurg and Cardiovascular. Within the Cardiovascular segment, the newly formed Cardiology division represents the combined former Rhythm Management and Interventional Cardiology businesses</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">We have revised prior period amounts to conform to the current year presentation. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">5. On March 1, 2021, we completed the sale of the Specialty Pharmaceuticals business. Our consolidated net sales include Specialty Pharmaceuticals up to the date of the closing of the transaction. Specialty Pharmaceuticals net sales were substantially U.S. based and presented as a stand-alone operating segment alongside our Medical Device reportable segments.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Net sales for the first quarter by business and region&#58;</font></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase&#47;(Decrease)</font></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br>March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less&#58; Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operational<br>&#160;Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less&#58; <br>Impact of Recent Acquisitions &#47; Divestitures</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Organic Basis</font></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Endoscopy</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">499&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Urology and Pelvic Health</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Neuromodulation</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MedSurg</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,153</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,058</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.0)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cardiology</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,407&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,248&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Peripheral Interventions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cardiovascular</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,873</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,681</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3.1)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Devices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,026</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,739</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(100.0)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(100.0)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(100.0)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,026</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,752</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.7)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase&#47;(Decrease)</font></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less&#58; Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operational<br>&#160;Basis</font></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,778&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,577&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.8&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.8&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APAC</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">517&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America and Canada</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Devices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,026</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,739</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(100.0)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(100.0)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,026</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,752</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Emerging Markets</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">3</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">390</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">317</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">22.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">28.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Amounts may not add due to rounding. Growth rates are based on actual, non-rounded amounts and may not recalculate precisely.</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Growth rates that exclude the impact of foreign currency fluctuations and&#47;or the impact of acquisitions &#47; divestitures are not prepared in accordance with U.S. GAAP.</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Guidance for Full Year and Second Quarter 2022</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The company now estimates net sales growth for the full year 2022, versus the prior year period, to be in a range of approximately 7 to 9 percent on a reported basis, and approximately 6.5 to 8.5 percent on an organic basis. Full year organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales. The company now estimates EPS on a GAAP basis in a range of $0.78 to $0.88 and estimates adjusted EPS, excluding certain charges (credits), of $1.74 to $1.79.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The company estimates net sales growth for the second quarter of 2022, versus the prior year period, to be in a range of approximately 3 to 6 percent on a reported basis and organic basis. Second quarter organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales. The company estimates EPS on a GAAP basis in a range of $0.19 to $0.23 and adjusted EPS, excluding certain charges (credits), of $0.41 to $0.43.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Conference Call Information</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston Scientific management will be discussing these results with analysts on a conference call today at 8&#58;00 a.m. ET. The company will webcast the call to interested parties through its website&#58; </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.bostonscientific.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Please see the website for details on how to access the webcast. The webcast will be available for approximately one year on the Boston Scientific website.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Boston Scientific</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.&#160; As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.bostonscientific.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and connect on </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Twitter</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Facebook</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Statements </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.&#160;Forward-looking statements may be identified by words like &#34;anticipate,&#34; &#34;expect,&#34; &#34;project,&#34; &#34;believe,&#34; &#34;plan,&#34; &#34;estimate,&#34; &#34;may,&#34; &#34;intend&#34; and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.&#160;These forward-looking statements include, among other things, statements regarding our expected net sales&#59; reported, operational and organic revenue growth rates&#59; reported and adjusted EPS for the second quarter and full year </font><font style="color:#003c71;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2022</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; our financial performance&#59; our business plans and product performance&#59; and the impact of the COVID-19 pandemic on the company's results of operations.&#160;If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.&#160;These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.&#160;As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Risks and uncertainties that may cause such differences include, among other things&#58; the impact of the ongoing COVID-19 pandemic on our operations and financial results&#59; future U.S. and global economic, political, competitive, reimbursement and regulatory conditions&#59; manufacturing, distribution and supply chain disruptions and cost increases&#59; disruptions caused by cybersecurity events&#59; disruptions caused by </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">extreme weather or other climate change-related events&#59; labor shortages and increases in labor costs&#59; new product introductions&#59; expected procedural volumes&#59; the closing and integration of acquisitions&#59; demographic trends&#59; intellectual property rights&#59; litigation&#59; financial market conditions&#59; the execution and effect of our business strategy, including our cost-savings and growth initiatives&#59; and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict, including those that have emerged or have increased in significance or likelihood as a result of the COVID-19 pandemic.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this press release.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Amounts reported in millions within this press release are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Non-GAAP Financial Information</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A reconciliation of the company's non-GAAP financial measures to the corresponding GAAP measures, and an explanation of the company's use of these non-GAAP financial measures,&#160;is included in the exhibits attached to this press release.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONTACT&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Media&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kate Haranis</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investors&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lauren Tengler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">508-683-6585 (office)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">508-683-4479 (office)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Media Relations</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investor Relations</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">kate.haranis&#64;bsci.com</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">BSXInvestorRelations&#64;bsci.com</font></td></tr></table></div><div id="i311b071536f440e0adcda33dd385265e_7"></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.597%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions, except per share data</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,026&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of businesses and assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss)&#160;before income taxes</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) available to common stockholders</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share - basic</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.07</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share - assuming dilution</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.07</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Weighted-average shares outstanding</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assuming dilution</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NON-GAAP NET INCOME AND NET INCOME PER SHARE RECONCILIATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Expenses</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Preferred Stock Dividends</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact per Share</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,071</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,605</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">466</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(310)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">156</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">110</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">97</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.07</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Non-GAAP adjustments&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(198)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">170&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">170&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition &#47; divestiture-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EU MDR implementation costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt extinguishment charges</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">194&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">194&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discrete tax items</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,127</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,346</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">781</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(110)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">671</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">575</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">562</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.39</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="30" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:115%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:115%"> For the three months ended March 31, 2022, the effect of assuming the conversion of Mandatory Convertible Preferred Stock (MCPS) into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP net income and adjusted net income were reduced by cumulative Preferred stock dividends, as presented in our unaudited consolidated statements of operations, for purposes of calculating net income available to common stockholders.</font></div></td></tr><tr style="height:12pt"><td colspan="30" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Expenses</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income (Loss) Before Income Taxes</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Preferred Stock Dividends</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Income (Loss) Available to Common Stockholders</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact per Share </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,858</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,488</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">370</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(45)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">325</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">341</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">327</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Non-GAAP adjustments&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(185)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">185&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">185&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">167&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">167&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition &#47; divestiture-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(37)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(198)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(148)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(153)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.11)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(31)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.00&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">EU MDR implementation costs</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discrete tax items</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.00)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,897</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,228</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">669</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(97)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">572</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">538</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(14)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">524</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.37</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="30" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> For the three months ended March 31, 2021, the effect of assuming the conversion of Mandatory Convertible Preferred Stock (MCPS) into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP net income and adjusted net income were reduced by cumulative Preferred stock dividends, as presented in our unaudited consolidated statements of operations, for purposes of calculating net income available to common stockholders.</font></div></td></tr><tr style="height:15pt"><td colspan="30" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">An explanation of the company's use of these non-GAAP financial measures is provided at the end of this document.</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Q2 and FY 2022 GUIDANCE RECONCILIATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">   </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Net Sales</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2022 Estimate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Full Year 2022 Estimate</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reported growth</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less&#58; Impact of foreign currency fluctuations</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Operational growth</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less&#58; Impact of certain acquisitions &#47; divestitures</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Organic growth</font></div></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Earnings per Share</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2022 Estimate</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Full Year 2022 Estimate</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Low)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(High)</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP results</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.78</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.88</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.48&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.48&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition &#47; divestiture-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.09&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.07&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt extinguishment charges</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted results</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.41</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.43</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.74</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.79</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i311b071536f440e0adcda33dd385265e_13"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share (EPS) that exclude certain amounts&#59; operational net sales, which exclude the impact of foreign currency fluctuations&#59; and organic net sales, which exclude the impact of foreign currency fluctuations as well as the impact of certain acquisitions and divestitures with less than a full period of comparable net sales. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To calculate adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share we exclude certain charges (credits) from GAAP net income (loss) and GAAP net income (loss) available to common stockholders. Amounts are presented after-tax at the company's effective tax rate, unless the amount is a significant unusual or infrequently occurring item in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 740-270-30, &#34;General Methodology and Use of Estimated Annual Effective Tax Rate.&#34; Please refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in our most recent Annual Report filed on Form 10-K filed with the Securities and Exchange Commission or any Quarterly Report on Form 10-Q that we file thereafter for an explanation of each of these adjustments and the reasons for excluding each item.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The GAAP financial measures most directly comparable to adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share are GAAP net income (loss), GAAP net income (loss) available to common stockholders and GAAP net income (loss) per common share - assuming dilution, respectively.  </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior periods. To calculate organic net sales growth rates, we also remove the impact of acquisitions and divestitures with less than a full period of comparable net sales. The GAAP financial measure most directly comparable to operational net sales and organic net sales is net sales on a GAAP basis. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the accompanying schedules.</font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales and profit or loss. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance. </font></div><div style="padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe that presenting adjusted net income (loss), adjusted net income (loss) available to common stockholders, adjusted net income (loss) per share, operational net sales growth rates and organic net sales growth rates, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision-making and </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bsx-20220427.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:23507074-9282-432b-a3e4-de757637ff25,g:77782b89-5359-4ad2-bba8-4b7412420161-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20220427" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20220427">
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20220427_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20220427_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20220427_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverDocument" roleURI="http://www.bostonscientific.com/role/CoverDocument">
        <link:definition>0001001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_A550MCPSSeriesAMember" abstract="true" name="A550MCPSSeriesAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>bsx-20220427_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:23507074-9282-432b-a3e4-de757637ff25,g:77782b89-5359-4ad2-bba8-4b7412420161-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20220427.xsd#CoverDocument"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended" id="i8fe71156cf75495fb4560b4f21771ab7_CoverDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_702bd1ad-d595-42eb-b49d-bff6a322f2c1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_DocumentType_702bd1ad-d595-42eb-b49d-bff6a322f2c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b9ff9cc9-0dd7-4f74-b953-6d10acadaa34" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_DocumentPeriodEndDate_b9ff9cc9-0dd7-4f74-b953-6d10acadaa34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_bfbc53c5-330c-4c6d-8d4d-99408266a662" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityRegistrantName_bfbc53c5-330c-4c6d-8d4d-99408266a662" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8f823d46-b2a7-4708-ace5-3d6a6265cb2e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_AmendmentFlag_8f823d46-b2a7-4708-ace5-3d6a6265cb2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b8656a8d-3329-464c-b7df-21955a881768" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b8656a8d-3329-464c-b7df-21955a881768" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c7d7fed1-9a84-4f78-9010-e55804da3fb9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityFileNumber_c7d7fed1-9a84-4f78-9010-e55804da3fb9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_08b1de56-3cb5-4ccb-8246-1b14eacb4ee9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityTaxIdentificationNumber_08b1de56-3cb5-4ccb-8246-1b14eacb4ee9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_172fbb69-c1a7-44af-bb06-d51f866084cf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityAddressAddressLine1_172fbb69-c1a7-44af-bb06-d51f866084cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4903fe38-0ea6-42e7-b863-377400c5740c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityAddressCityOrTown_4903fe38-0ea6-42e7-b863-377400c5740c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d5295196-72ac-45c0-9528-35f47ff75203" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityAddressStateOrProvince_d5295196-72ac-45c0-9528-35f47ff75203" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2b020b5d-cbe7-476b-8ff7-536cc8dc4798" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityAddressPostalZipCode_2b020b5d-cbe7-476b-8ff7-536cc8dc4798" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0c3798d1-7625-47bd-8d6e-e1f8d6857b6c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_CityAreaCode_0c3798d1-7625-47bd-8d6e-e1f8d6857b6c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5a9cf11a-2985-4610-9645-b04396beca8d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_LocalPhoneNumber_5a9cf11a-2985-4610-9645-b04396beca8d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5a6f465c-4763-461f-b21c-6f694fd1e40c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_WrittenCommunications_5a6f465c-4763-461f-b21c-6f694fd1e40c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_5da3e502-9b51-4e9e-b14b-ce57e96004af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_SolicitingMaterial_5da3e502-9b51-4e9e-b14b-ce57e96004af" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_facaf2e0-7558-43ac-b1ef-74be58a1fceb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_PreCommencementTenderOffer_facaf2e0-7558-43ac-b1ef-74be58a1fceb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_1c263d2c-69ff-4883-8652-a7864b8e2eca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_1c263d2c-69ff-4883-8652-a7864b8e2eca" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b9157f57-9970-4fb6-b657-58585b307511" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_Security12bTitle_b9157f57-9970-4fb6-b657-58585b307511" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d2b90a04-fec2-4f28-9eae-4220ced63bde" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_TradingSymbol_d2b90a04-fec2-4f28-9eae-4220ced63bde" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_002d1361-741e-4d9d-96b6-f4cb66009390" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_SecurityExchangeName_002d1361-741e-4d9d-96b6-f4cb66009390" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f949d675-10a4-43a4-bc10-42f48c2ea04e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityEmergingGrowthCompany_f949d675-10a4-43a4-bc10-42f48c2ea04e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e4a98493-356f-4018-888f-e30991db56b5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityCentralIndexKey_e4a98493-356f-4018-888f-e30991db56b5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_8fe440a4-f438-4087-8617-4d104b0fa64f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntitiesTable_8fe440a4-f438-4087-8617-4d104b0fa64f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_26cd87d0-725e-4542-ab98-fa2d957ffc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_8fe440a4-f438-4087-8617-4d104b0fa64f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_26cd87d0-725e-4542-ab98-fa2d957ffc8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_26cd87d0-725e-4542-ab98-fa2d957ffc8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_26cd87d0-725e-4542-ab98-fa2d957ffc8d" xlink:to="loc_us-gaap_ClassOfStockDomain_26cd87d0-725e-4542-ab98-fa2d957ffc8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_26cd87d0-725e-4542-ab98-fa2d957ffc8d" xlink:to="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9eb93f4a-1394-488c-a974-7d25f02e55c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:to="loc_us-gaap_CommonStockMember_9eb93f4a-1394-488c-a974-7d25f02e55c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_9989c473-915d-4071-bdd6-1551e9b32f0c" xlink:href="bsx-20220427.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:to="loc_bsx_SeniorNotedue2027Member_9989c473-915d-4071-bdd6-1551e9b32f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_c2cb8045-68ad-4052-9c0a-557b55e51ba8" xlink:href="bsx-20220427.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:to="loc_bsx_A550MCPSSeriesAMember_c2cb8045-68ad-4052-9c0a-557b55e51ba8" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>bsx-20220427_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:23507074-9282-432b-a3e4-de757637ff25,g:77782b89-5359-4ad2-bba8-4b7412420161-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_bsx_A550MCPSSeriesAMember_3ef409e3-f89f-49b4-a015-65f48b6567ca_terseLabel_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_label_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_documentation_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember" xlink:href="bsx-20220427.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A550MCPSSeriesAMember" xlink:to="lab_bsx_A550MCPSSeriesAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8ba66083-974d-412d-bba3-db8b35c5dd2a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_586e60dc-e977-4956-8651-aea97b96da81_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b82ab6b7-3fc4-45a3-8578-c6dea6feeb32_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_58e17e19-ff9a-4e41-84ca-b2af09dc263f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_0e14b8fd-311e-421f-b1bb-b061a94ee07b_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_27acbf78-29cb-4c64-8007-432217b97fca_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_73ef77d5-c279-4f4e-8d31-94411184bdb9_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_12cdfac0-2049-4881-a010-49484db9f3cd_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_dab0b53c-344f-4467-950b-1875db83f4a9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e9449757-49d8-497b-a98b-e702f219f60f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_b4c1abf3-39a3-44ae-806c-f25bd67b541f_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ba1f6a35-c6cc-4a33-b841-6fa0d663119f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_00dca938-7065-4e07-9527-8eb4aead7706_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20220427.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_4f76482b-a373-4707-a2c9-9f3cd3cd95f3_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_32fc8739-861b-491d-b714-ae700524b63b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_6216175b-a561-4ef6-9ccd-cd33aee041ba_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_3b32307f-8092-448a-a595-c5e4b3675e9f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_9c3cfe47-558e-47a8-bba8-22558f89931c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_08f4ba1c-4c69-475b-852c-230cb171209f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_485de978-aa93-4dad-9374-462113866a46_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_d9bf1310-7461-4207-93e2-4e2eb971afb1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6c146783-38d9-41d2-a2b0-c0c39ba97038_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_59e0ab3a-c0f0-401f-96be-375835bc9730_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ff5bbf15-978e-4548-9b37-d72dcd873df3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_dc1778c1-830a-4cc9-8c71-3d776a1dde85_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1a3a1ad6-2d3a-45f1-beba-1948651fe94f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_db055157-9f50-4f7e-8e4d-8ebd5ec161e1_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_36879d8c-53f3-4f88-9380-b0b002da277b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_0747367c-6ba9-47c7-96be-fa1f73fc8ccc_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>bsx-20220427_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:23507074-9282-432b-a3e4-de757637ff25,g:77782b89-5359-4ad2-bba8-4b7412420161-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20220427.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_790b6ffc-eaca-4a4c-913a-5dd3545e4eab" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_8fe440a4-f438-4087-8617-4d104b0fa64f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_790b6ffc-eaca-4a4c-913a-5dd3545e4eab" xlink:to="loc_dei_EntitiesTable_8fe440a4-f438-4087-8617-4d104b0fa64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_26cd87d0-725e-4542-ab98-fa2d957ffc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_8fe440a4-f438-4087-8617-4d104b0fa64f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_26cd87d0-725e-4542-ab98-fa2d957ffc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_26cd87d0-725e-4542-ab98-fa2d957ffc8d" xlink:to="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9eb93f4a-1394-488c-a974-7d25f02e55c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:to="loc_us-gaap_CommonStockMember_9eb93f4a-1394-488c-a974-7d25f02e55c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_9989c473-915d-4071-bdd6-1551e9b32f0c" xlink:href="bsx-20220427.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:to="loc_bsx_SeniorNotedue2027Member_9989c473-915d-4071-bdd6-1551e9b32f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_c2cb8045-68ad-4052-9c0a-557b55e51ba8" xlink:href="bsx-20220427.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_abd9f5b8-7dc4-4a81-b4f2-93beb03ffacf" xlink:to="loc_bsx_A550MCPSSeriesAMember_c2cb8045-68ad-4052-9c0a-557b55e51ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_8fe440a4-f438-4087-8617-4d104b0fa64f" xlink:to="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_702bd1ad-d595-42eb-b49d-bff6a322f2c1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_DocumentType_702bd1ad-d595-42eb-b49d-bff6a322f2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b9ff9cc9-0dd7-4f74-b953-6d10acadaa34" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_DocumentPeriodEndDate_b9ff9cc9-0dd7-4f74-b953-6d10acadaa34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_bfbc53c5-330c-4c6d-8d4d-99408266a662" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityRegistrantName_bfbc53c5-330c-4c6d-8d4d-99408266a662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8f823d46-b2a7-4708-ace5-3d6a6265cb2e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_AmendmentFlag_8f823d46-b2a7-4708-ace5-3d6a6265cb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b8656a8d-3329-464c-b7df-21955a881768" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b8656a8d-3329-464c-b7df-21955a881768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c7d7fed1-9a84-4f78-9010-e55804da3fb9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityFileNumber_c7d7fed1-9a84-4f78-9010-e55804da3fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_08b1de56-3cb5-4ccb-8246-1b14eacb4ee9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityTaxIdentificationNumber_08b1de56-3cb5-4ccb-8246-1b14eacb4ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_172fbb69-c1a7-44af-bb06-d51f866084cf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityAddressAddressLine1_172fbb69-c1a7-44af-bb06-d51f866084cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4903fe38-0ea6-42e7-b863-377400c5740c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityAddressCityOrTown_4903fe38-0ea6-42e7-b863-377400c5740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d5295196-72ac-45c0-9528-35f47ff75203" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityAddressStateOrProvince_d5295196-72ac-45c0-9528-35f47ff75203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2b020b5d-cbe7-476b-8ff7-536cc8dc4798" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityAddressPostalZipCode_2b020b5d-cbe7-476b-8ff7-536cc8dc4798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0c3798d1-7625-47bd-8d6e-e1f8d6857b6c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_CityAreaCode_0c3798d1-7625-47bd-8d6e-e1f8d6857b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5a9cf11a-2985-4610-9645-b04396beca8d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_LocalPhoneNumber_5a9cf11a-2985-4610-9645-b04396beca8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5a6f465c-4763-461f-b21c-6f694fd1e40c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_WrittenCommunications_5a6f465c-4763-461f-b21c-6f694fd1e40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_5da3e502-9b51-4e9e-b14b-ce57e96004af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_SolicitingMaterial_5da3e502-9b51-4e9e-b14b-ce57e96004af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_facaf2e0-7558-43ac-b1ef-74be58a1fceb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_PreCommencementTenderOffer_facaf2e0-7558-43ac-b1ef-74be58a1fceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_1c263d2c-69ff-4883-8652-a7864b8e2eca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_1c263d2c-69ff-4883-8652-a7864b8e2eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b9157f57-9970-4fb6-b657-58585b307511" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_Security12bTitle_b9157f57-9970-4fb6-b657-58585b307511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d2b90a04-fec2-4f28-9eae-4220ced63bde" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_TradingSymbol_d2b90a04-fec2-4f28-9eae-4220ced63bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_002d1361-741e-4d9d-96b6-f4cb66009390" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_SecurityExchangeName_002d1361-741e-4d9d-96b6-f4cb66009390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f949d675-10a4-43a4-bc10-42f48c2ea04e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityEmergingGrowthCompany_f949d675-10a4-43a4-bc10-42f48c2ea04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e4a98493-356f-4018-888f-e30991db56b5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c47b0859-3ffa-445d-8469-d85594ff56a0" xlink:to="loc_dei_EntityCentralIndexKey_e4a98493-356f-4018-888f-e30991db56b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
MB5!.1PT*&@H    -24A$4@  ! H   "6" 8   !73VH'     7-21T( KLX<
MZ0    1G04U!  "QCPO\804    )<$A9<P  %Q$  !<1 <HF\S\  )5I241!
M5'A>[9T'?%1%U\8#V+%BU_?UT]?>&Z H3004%2PHJ"@*2 ^]]]Y[[QVD]PY)
MZ"4)O??>>X?0GN\\L_<FF\W=S:8L!#A_?\<EN[?,G3MW[IQG9LX$05$415$4
M15$415$4Q4*% D51%$51%$51%$51HE&A0%$415$415$415&4:%0H4!1%411%
M411%410E&A4*%$51%$51%$51%$6)1H4"15$415$415$415&B4:% 411%411%
M411%491H5"A0%$51%$51%$51%"4:%0H415$415$415$418E&A0)%411%411%
M411%4:)1H4!1%$51%$51%$51E&A4*% 415$415$415$4)1H5"A1%411%411%
M411%B4:% D51%$51%$51%$51HE&A0%$415$415$415&4:%0H4!1%411%411%
M410E&A4*%$51%$51%$51%$6)1H4"15$415$415$415&B4:% 411%411%411%
M491H5"A0%$51%$51%$51%"4:%0H415$415$415$418E&A0)%411%411%46X+
M+ERZC+4[#F+YYKU8N64?UFP[@'4[#V&=?&=LYT'S'7];N74_5HGQ^VW[CF+_
MT5.(NGS%.I*BW-FH4* HBJ(HBJ(HRFW!AEV'\%'1=G@Z7WV\D+\Q'O^V+A[X
ML@8>R&F9_)O?\;?G?FB(1[^NC;NS5\7#N6OAY0)-D;=Z;]3N-043YJ_%P6.G
MK:,JRIV'"@6*HBB*HBB*HMP6G+UP"0O7[$#8LBV8OVH["M0?A*"/RB H4WD$
M?2J6OBP*-1YB?IL9L0FCPE:AY9 0Y*K4 T&?54#0&\40]%Y)W).U"CXLT@8=
M1\W%Y2LZRD"Y\U"A0%$415$415&4VY(ZO:<:<2 H<R4$?58109^40Z,!,ZQ?
M8S-A_AJ\^7L+U_:6J$#[N_EP'#MUSMI*4>X,4IQ0<.K<1?,@7KUVS?HF^;EZ
M";A\2CXO6E\$@.MBQ^5_)_@/)0X7HZY@W['3.'GV@O6-HBB*HBB*HB0O-7I,
MCB,4U.L[S?HU+FNW'T#Z8NUDGV#7/A0,/BJ-JMTFXMIU;=@K=PXI1BA8L&8'
M*G4<CXS%V^/-/UKAE]K],63F,IR[&&5MD70N'@9V#0:6E0(6_RR?_P [^@ 7
M]ED;) ,7I/X8(TG^XQSPSFG@ ['2\N^YEZT-%,/$A>OPY)?54:3Y<.L;15$4
M15$414E>$BH4D.E+-^+!G#5<(@'WDWT8PV#UUOW6%HIR^W/3A0*.'&@Q)$0>
MOIH(>K>$ZT'.&(R@#TK)0UD>W]?HBQ6;D^[)'UL*+"DH#_YKP(PW@)EONS[Y
M]Z*?@/V3K0V3P+YK0*&SDJDGQ(['M@?ENZH7@*,J1!HH @6]5!@Y*_:POE$4
M15$415&4Y"4Q0@$[*DW, N[WN>SWN>PG_VX\<*:UQ:W'M6O7 SIB6[G]N.E"
M0=OA80C*6,XE#O !=K=,%1#T<1G\+W]CC)F[VMHCX9S;"2S,"TQ_%9C]H=A'
M;B9_4S (R0!L[2H/42(',)RY#OQ,D8#" (4")Y/?<IX!-ERU=KJ#^7?V<@2]
M7A1YJO:VOE$415$415&4Y"4Q0@&IT'$<@C*(?T*1@/N*3_)M]3[6K[<6% CJ
M]YV.Q>O$*5(4/[FI0L&VO4?QOP)-8QY>;_9Q63/\I^V(.8BZG' O>WU#U\B!
M."*!F\U\US7*8$U-X/P>:\<$,#P*2.TD#GC:<>"-4\"T.WPJ@@H%BJ(HBJ(H
M2J!)K%!0I_>TV$+!1V60HT)WZ]=;BXV[#N/%GYM@\L+UUC>*$C\W52@8&;(2
MJ;-4=HT<<!<&G$P>:C[<A9L.PY&39ZTCQ,_% \#\KX 9;SD+!.XVZWU@^AO
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MP2N_-,'(T/B[_8\N $(S ;/><Q %?-B,MX&0C,#FCL!5<>9]P<D0C#V04*'
MF.S#?===<1WK3D&% D51%$51%"70)$8HV''@&%[]M;EK1 'WD_TY='_/H9/6
M%K<.=?I,->E_*'=-A*E0H"2 FRH4-!J0"*& 1F7OXS)XY,OJZ#ARGEF3WQM'
M%R9.**!Q% *G(JRN!ISW,8"!0D&NQ H%--GO]3LL;H$*!8JB*(JB*$J@28Q0
MT*#?=)>/0I^# =<SE$7+H2'6K_[!40F'3Y[%S@/'L>O@"1P[=0[7$SF*^.R%
M2]AY\+@1,$Z=O6!]Z^+RE:MF=+,GNP^=,*LT/)"]JO&;'OVZ%I:L37@P0ZX
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MB-/,'GE?L/<_>[FN9@H"IT^G+][!!/.SV7OX)%[[K3G2YJJ)\ V[K&^=X50
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M>DS,<!IA&<793Z)8$$<H"%MFQ()[YB['DUL.X[X3UP,:M^ +QBVX!9<65:%
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M*[-VM7'D;8'!-CG_@[+O<#_BI:S9N LO,B:%G7<TZ]HYE>;=7YN:&!)UND]
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MEOO6H,=$7$I@KP;STJQ$X&74D4W4Y<OXL\$@JZS(^7A>GC]3>5./,="H/S"
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MG<>ZKHO.G].^4GX>^K(:&O:>@D-'I( ' *]" =/$O/5J;MMZFI05SF/_N_X
MK-L2$V3)'[J.G"/7+6GARX_'DOSYL6J/.(V.Q#(G<A,>RRUU-IU+2_SZN^%
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M%,Q9NLZL3A&=AS<BW7*?'\U9#9MWQETV\LRY"RC2<) 1P\R[RRZ?5D.'WS'
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M4*'@E#BW7Y3I%#O=<HWO_-$"AX_%G:^9W&S8<0#W,8]Y_WANR>ND"@5GSUU
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M5\4>:#)P%EH,F8U<E7J@^_B%YK>;Q:TO%# >P4=E\,%?K3%MZ0;KR#$DEU#
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0>6FE=     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139873036899112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Document<br></strong></div></th>
<th class="th"><div>Apr. 27, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 27,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>bsx-20220427_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20220427"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bsx-20220427.xsd" xlink:type="simple"/>
    <context id="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2022-04-27</startDate>
            <endDate>2022-04-27</endDate>
        </period>
    </context>
    <context id="icb4a424e51c34eb6b267543ce629927f_D20220427-20220427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-27</startDate>
            <endDate>2022-04-27</endDate>
        </period>
    </context>
    <context id="i251eeeeb4e07422da696af078158cb33_D20220427-20220427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-27</startDate>
            <endDate>2022-04-27</endDate>
        </period>
    </context>
    <context id="i61064d33ffc241bea390f6765d527888_D20220427-20220427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-27</startDate>
            <endDate>2022-04-27</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl80L2ZyYWc6OTMzYzk4ZmY1OWE4NDNmOGJlNjg4ZDdlOGRkNjA0MmYvdGFibGU6ZjhkMzBiZGVjZWNkNGM4Njk3YzdjODJhZjg2MTI5MzQvdGFibGVyYW5nZTpmOGQzMGJkZWNlY2Q0Yzg2OTdjN2M4MmFmODYxMjkzNF8yLTEtMS0xLTY4OTc1_f7287cb7-2f93-48da-b33f-382a3fe5ecb8">0000885725</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl80L2ZyYWc6OTMzYzk4ZmY1OWE4NDNmOGJlNjg4ZDdlOGRkNjA0MmYvdGFibGU6ZjhkMzBiZGVjZWNkNGM4Njk3YzdjODJhZjg2MTI5MzQvdGFibGVyYW5nZTpmOGQzMGJkZWNlY2Q0Yzg2OTdjN2M4MmFmODYxMjkzNF81LTEtMS0xLTY4OTc1_b0be00be-657a-42ca-911f-13d1b0a78e4f">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDUy_433644c5-d606-4d10-bec0-2f7dc5f9a0de">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8zNjc_cac18df7-b62e-4737-bb94-373fa0818c39">2022-04-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDUz_28d48206-d18e-4492-b078-ee96c952c3c4">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6NmQzN2I4NzY5ZWY0NDc3NDhkYmY2Zjk5MGYzOGJlYTMvdGFibGVyYW5nZTo2ZDM3Yjg3NjllZjQ0Nzc0OGRiZjZmOTkwZjM4YmVhM18wLTAtMS0xLTY4OTc1_9f0af190-78e5-4b54-a884-fcbb3c0b55ec">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6NmQzN2I4NzY5ZWY0NDc3NDhkYmY2Zjk5MGYzOGJlYTMvdGFibGVyYW5nZTo2ZDM3Yjg3NjllZjQ0Nzc0OGRiZjZmOTkwZjM4YmVhM18wLTItMS0xLTY4OTc1_9fc12eb2-5b1c-4db9-a3de-e837422bbfb2">1-11083</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6NmQzN2I4NzY5ZWY0NDc3NDhkYmY2Zjk5MGYzOGJlYTMvdGFibGVyYW5nZTo2ZDM3Yjg3NjllZjQ0Nzc0OGRiZjZmOTkwZjM4YmVhM18wLTQtMS0xLTY4OTc1_1b80a121-a68a-4fa0-8901-f50021db5bf0">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDU0_42902cf9-c841-4572-845c-94d9ad06595b">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDQ4_7cd20ef1-2fc2-4285-9442-e6a945c7bfcd">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDU1_72f73408-1ceb-470b-b9c8-e33124c8832b">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDQ5_38367582-b3cf-44cd-9bb6-386c1fc756f3">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDUw_1107445f-0edb-4d29-bfc2-d5fc15881a53">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDU2_35b59e2e-ff83-4b9b-a124-8fd5081f4bef">683-4000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6MGY2ZDIyNmM4MWJiNGY1NmJkYTIwZDE3MGNlYjQ5MTMvdGFibGVyYW5nZTowZjZkMjI2YzgxYmI0ZjU2YmRhMjBkMTcwY2ViNDkxM18wLTAtMS0xLTY4OTc1_2e1afbb1-6259-4549-a422-fbb5fcfca98a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6MGY2ZDIyNmM4MWJiNGY1NmJkYTIwZDE3MGNlYjQ5MTMvdGFibGVyYW5nZTowZjZkMjI2YzgxYmI0ZjU2YmRhMjBkMTcwY2ViNDkxM18yLTAtMS0xLTY4OTc1_42c7c74a-a06e-459d-9ea0-7aed9b95a7a3">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6MGY2ZDIyNmM4MWJiNGY1NmJkYTIwZDE3MGNlYjQ5MTMvdGFibGVyYW5nZTowZjZkMjI2YzgxYmI0ZjU2YmRhMjBkMTcwY2ViNDkxM180LTAtMS0xLTY4OTc1_5cf1efb0-0129-4011-88b8-e4a1b21d57ef">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6MGY2ZDIyNmM4MWJiNGY1NmJkYTIwZDE3MGNlYjQ5MTMvdGFibGVyYW5nZTowZjZkMjI2YzgxYmI0ZjU2YmRhMjBkMTcwY2ViNDkxM182LTAtMS0xLTY4OTc1_4af56113-ef7a-4b70-b39d-adb7b0193c4a">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="icb4a424e51c34eb6b267543ce629927f_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18xLTAtMS0xLTY4OTc1_5c180c5b-d39a-44b7-9041-df54df0fa490">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icb4a424e51c34eb6b267543ce629927f_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18xLTItMS0xLTY4OTc1_c7af3bb5-af38-40f1-9b14-996708d9b36c">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="icb4a424e51c34eb6b267543ce629927f_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18xLTQtMS0xLTY4OTc1_80833b14-5dfd-4ca4-8f0c-4fd818ed73f4">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i251eeeeb4e07422da696af078158cb33_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18yLTAtMS0xLTY4OTc1_debe8456-3952-44d0-a33c-4f9efe9c2afd">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i251eeeeb4e07422da696af078158cb33_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18yLTItMS0xLTY4OTc1_3b5e0f33-d1b0-4393-ab1a-ca40268906e3">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i251eeeeb4e07422da696af078158cb33_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18yLTQtMS0xLTY4OTc1_61df86f9-e886-4b12-92eb-cf7a1bf88e14">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i61064d33ffc241bea390f6765d527888_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18zLTAtMS0xLTY4OTc1_ebac21b6-3f22-47e9-bbee-7ccbf66b6d00">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i61064d33ffc241bea390f6765d527888_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18zLTItMS0xLTY4OTc1_8d55d403-1221-402d-aa6a-b34884f534a2">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i61064d33ffc241bea390f6765d527888_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGFibGU6YmY3ZTE0ZjM4ZTE0NGNjNmIyMTIwMDRiMWQwNDBiMmMvdGFibGVyYW5nZTpiZjdlMTRmMzhlMTQ0Y2M2YjIxMjAwNGIxZDA0MGIyY18zLTQtMS0xLTY4OTc1_44c17c89-44c6-4d38-9c05-56a9ff2796c6">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="if3eed0c2860140a1b892af6324a91d21_D20220427-20220427"
      id="id3VybDovL2RvY3MudjEvZG9jOjA5NDhlNDg3NDBkZjQ2MTRiOTc2ZGI2YTAyZjg2NGI2L3NlYzowOTQ4ZTQ4NzQwZGY0NjE0Yjk3NmRiNmEwMmY4NjRiNl8xL2ZyYWc6YWVmYjBkYWExOWNkNDJhYzlhNzJhNzMxODdmMmY2MTYvdGV4dHJlZ2lvbjphZWZiMGRhYTE5Y2Q0MmFjOWE3MmE3MzE4N2YyZjYxNl8xNDUx_f5b51733-4968-46aa-a192-48771901f533">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MING@'E=>BR4"4(LX2FZ2#NYLUU=CB5!)-3JY.3JX.39K3>L]>1S.7&B!H3>
MY&--K'/V0N.MO-')O='Y;MY8HG1, Y,^,RI]+I;/7!NQ!'WH"F#?U]P_6><I
M3S=G]GFTTRM,U,E-U/E6$RT1@,(ELSD^H;F3.M_+24N$+M5N_>R%8?+R%9[X
MH,F)2<!7H&/5VC!8?7B?>3@Q*DK?(2Z5,2I,#S><0:>67 #_KQ28R?$D>2V9
MO57N_0-02P,$%     @ :#2;5)^@&_"Q @  X@P   T   !X;"]S='EL97,N
M>&ULW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG
M:75EW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<
M>Z0R5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6
ME :#7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,H
MH8T%8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+
M3HOE+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC
M%'S8 Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/
MQGWL_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8
M\>2SP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W
M5_DMC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\
M*KY?7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76
M^T$D7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1G
MA?H$KQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ
M;N,3\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:
M0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88 J<11S &P %#
MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ :#2;5)>*NQS     $P(   L
M  !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%
MG;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XU
MA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.
M\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,B
MM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !H-)M4-]1K_C8!
M   K @  #P   'AL+W=O<FMB;V]K+GAM;(U1T6[", S\E2H?L!:T(0U17D#;
MD*8-C8GWT+K4(HDKQX6-KY_;JAK27O:4W-FZW%T6%^+3@>B4?'D78FYJD6:>
MIK&HP=MX1PT$G53$WHI"/J:Q8;!EK '$NW2:9;/46PQFN1BUMIS> A(H!"DH
MV1%[A$O\G7<P.6/$ SJ4[]ST=P<F\1C0XQ7*W&0FB35=7HCQ2D&LVQ5,SN5F
M,@SVP(+%'WK7F?RTA]@S8@\?5HWD9I:I8(4<I=_H]:UZ/(,N#Z@5>D(GP&LK
M\,S4-AB.G8RF2&]B]#V,YU#BG/]3(U45%K"FHO409.B1P74&0ZRQB28)UD-N
M5G0&3L;%+IB^M"F'D*+N;BKC.>J -^7@<S170H4!RC?5B\IK4<66D^[H=:;W
M#Y-'+:1U;J7<>W@E6XY9QW]:_@!02P,$%     @ :#2;5"0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( &@TFU1ED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    " !H-)M4B@D!K>\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !H-)M4
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( &@TFU2H!?^E'04  &$6   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !H-)M4
MGZ ;\+$"  #B#   #0              @ %A#0  >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( &@TFU27BKL<P    !,"   +              "  3T0  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( &@TFU0WU&O^-@$  "L"   /
M      "  281  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !H-)M4)!Z;
MHJT   #X 0  &@              @ &)$@  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " !H-)M499!YDAD!  #/ P  $P
M    @ %N$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  "X
%%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bsx-20220427.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bsx-20220427.htm">bsx-20220427.htm</File>
    <File>bsx-20220427.xsd</File>
    <File>bsx-20220427_def.xml</File>
    <File>bsx-20220427_lab.xml</File>
    <File>bsx-20220427_pre.xml</File>
    <File>q12022earningsrelease.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bsx-20220427.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "definitionLink": {
     "local": [
      "bsx-20220427_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bsx-20220427.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20220427_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20220427_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20220427.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20220427",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220427.htm",
      "contextRef": "if3eed0c2860140a1b892af6324a91d21_D20220427-20220427",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Document",
     "role": "http://www.bostonscientific.com/role/CoverDocument",
     "shortName": "Cover Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20220427.htm",
      "contextRef": "if3eed0c2860140a1b892af6324a91d21_D20220427-20220427",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.50% MCPS, Series A",
        "label": "5.50% MCPS, Series A [Member]",
        "terseLabel": "5.50% MCPS, Series A"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://www.bostonscientific.com/20220427",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SeniorNotedue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "terseLabel": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNotedue2027Member",
     "nsuri": "http://www.bostonscientific.com/20220427",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000885725-22-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-22-000011-xbrl.zip
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M&]>U_N@+[8W;PP:TH='UYCWZ-6CN'2^N78&GDC"?<X(MJF)EF(:+F4$IAM]
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M[)D.Q]8Z?3V5XXSLSQ3JZBR.U6[QU44Y*HSH.EH#R)M+HZ8<86&823LNP5(
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M#>XY.!Y*/!)+>!NFXW#W?U!+ P04    " !H-)M4:=NC4$P#  "J"P  $
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M@CBK_P;#K97O-,'^[GKP48F7DS6'P,3BRZL7R\OM2_O(\*L7_P502P,$%
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M;MB'%F>)=H;>(%7-2EX#7QZ\T*N:5N7JG5JX((3+9V']U.YE%!EW!KF2<_?
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M"3\(&8N:X)0@&C\2V,@G[X5<"0>WS*YY0O@]0#Q=V(U8-#[#2='MY93M1[]
M_W.(2D1%A*"1R*A1C203<0[G3:ZUUYJO8+FX;74]A<1OXF*TK&O&8@^A3AW8
M[^;^!-=.RT62F@3ND6=#+?$1,(Z$/G.M8N PBH=;Y@:!(+<$A*<+N1$3PT$9
MJ_JLJGLU^LV9_>J\;.NK_2HAT%9CW#8AT-P1J64DP:1,.'-*>6N9T78E9>4C
M3@RB16T)+:L6?2,8>E?,X>/Y=3=EDLF0&''>RFYAM,111@DHA4U6\B*'QS:M
MA@+SW>(@.O16T?%$.3<"A6-_>9!NOECL1;D)A-K $BA-1 Q82L<8B.4X3;+
M)/@8), JN/B)^4&0F*V"9!5";P0Q>REA/IJ;7YT\;,8,SR&@%I%UJZCTF81
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MTD&M ),[9H<!LBV;H..571D:+Z?W%,7XOKY^=O-"]]#]Y_OK9_\'4$L#!!0
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MPI/W)?6_4WQ2[%*?>\.3O[5"3KV_%23 J2A9R+OZL>1_L1.[#.-2_WS40V_
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MQ;\S4.9]$; A<*1/>>C30+6 S.RF@X#V11?T. L+L\K=(LGT_@!,0$<#CX&
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MP8,2L23,[PB/_Z7IF_@=F+X<]"&^\DCB1$8@6;I>4$]\:L:@0/K(#JD^9C^
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MM>1?'W42I8?NW0 ^<?@ 8>2+6/N$%]_NBD!E7))5VJ8-GB8HL&L1L61[:,2
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M.JK63-"SB#B-S9N'?!/(>&(&1H9 1LZR024#HV<#GM+FK\;;(Q_Z#OSE,';
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M,_A_R!CQX8.^)"QPF4NN:.CT2<4ND'*I7"ZHUUBWRYR(B"ZA4L8^<$G][(@
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MROTKW+@605'5KNEB-54X]N%]K3E#XMP4'JWMU0QHDY?(@*'/$OKLT6F*+5_
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M3@:5$?RA;L?&@8H!"]6HH1&8&AG$(< HH4DZ)Z#VY,@?*/<HDA8H.$FWOO!
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MP)_(Y,S!]Z0W@)^D;IB,P;E;3=/F .&?.L(=PA_]R/=^_?]02P$"% ,4
M" !H-)M4F3-*(&(6  "LFP  $               @ $     8G-X+3(P,C(P
M-#(W+FAT;5!+ 0(4 Q0    ( &@TFU1IVZ-03 ,  *H+   0
M  "  9 6  !B<W@M,C R,C T,C<N>'-D4$L! A0#%     @ :#2;5%:QUFZX
M"   *SX  !0              ( !"AH  &)S>"TR,#(R,#0R-U]D968N>&UL
M4$L! A0#%     @ :#2;5(1]%%]*#0  9'L  !0              ( !]"(
M &)S>"TR,#(R,#0R-U]L86(N>&UL4$L! A0#%     @ :#2;5.T[GF],"
MQT   !0              ( !<#   &)S>"TR,#(R,#0R-U]P<F4N>&UL4$L!
M A0#%     @ :#2;5/_T7E7\0    !P$ !D              ( ![C@  '$Q
M,C R,F5A<FYI;F=S<F5L96%S92YH=&U02P4&      8 !@") 0  (7H

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
